Boston’s Life Sciences Sector Faces Challenges But Remains a Magnet for Investment and NIH Funding

April 14, 2025 at 04:20 PM
Share & Print
NOT FOR REPRINT

© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Related Stories

Gillette Plans Almost $1B Investment After Acquiring New Boston HQ Oxford Returns to Buying Office in Boston, With $435M Acquisition Greater Boston Multifamily Rent Growth Slows to Near 5-Year Low Office in Boston on Best Absorption Run Since 2018 Greater Boston Multifamily Vacancy Continues To Rise, but Stabilization Is in Sight Boston Office Fundamentals Set for 2026 Improvement Amid Record Availability